Drug Search

Main Content

 

                        Medicare-Approved 2022 Venture Formulary: 22037

5 Tier Venture Formulary

Download the latest comprehensive copy of the Medicare Part-D formulary with prior authorization here.

For detailed instructions on how to use this site, please click here

All drugs returned upon search are covered on the formulary. The formulary status (e.g., tier) and any applicable coverage restrictions (e.g., prior authorization, quantity limit) are denoted by symbols. A “Definition of Symbols” is displayed immediately following the search results.

 

To access the 2023 Venture Formulary click here


18212

Drug Search Main Content

Alphabetical Search Skip to Brand & Generic Search
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  Loading...

Therapeutic Class Search Skip to Footer

  • ANTI - INFECTIVES
  • ANTINEOPLASTIC / IMMUNOSUPPRESSANT DRUGS
  • AUTONOMIC / CNS DRUGS, NEUROLOGY / PSYCH
  • CARDIOVASCULAR, HYPERTENSION / LIPIDS
  • DERMATOLOGICALS/TOPICAL THERAPY
  • DIAGNOSTICS / MISCELLANEOUS AGENTS
  • EAR, NOSE / THROAT MEDICATIONS
  • ENDOCRINE/DIABETES
  • GASTROENTEROLOGY
  • IMMUNOLOGY, VACCINES / BIOTECHNOLOGY
  • MISCELLANEOUS SUPPLIES
  • MUSCULOSKELETAL / RHEUMATOLOGY
  • OBSTETRICS / GYNECOLOGY
  • OPHTHALMOLOGY
  • RESPIRATORY AND ALLERGY
  • UROLOGICALS
  • VITAMINS, HEMATINICS / ELECTROLYTES
©1997-2025 Managed Markets Insight and Technology, LLC. All Rights Reserved Terms of Use

Federal Contracting Statement:

Highmark Choice Company, Highmark Senior Health Company, Highmark BCBSD Inc. and Highmark Senior Solutions Company are Medicare Advantage plans with a Medicare contract. Highmark Health Insurance Company is a PDP plan with a Medicare contract. Enrollment in Highmark Choice Company, Highmark Senior Health Company, Highmark Senior Solutions Company, Highmark BCBSD Inc., and Highmark Health Insurance Company depends on contract renewal

Disclaimer

Formulary Id: 22037
Formulary Effective Date: 12/01/2022
Updated:
12/2022
CMS Approval Date:
12/01/2022
CMS Version:
25
CMS Marketing Materials Id:
Y0037_21_4400_C

Top of Page